#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arteriovenous malformation Hyperchylomicronaemia Carcinoid syndrome Pemphigus Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Methylmalonic acidaemia Hypochondroplasia Gastrointestinal disorder Pseudoxanthoma elasticum Small cell lung cancer limited stage Meningococcal immunisation Laryngeal squamous cell carcinoma Prostate cancer B-cell small lymphocytic lymphoma refractory Henoch-Schonlein purpura nephritis More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Treatment Langerhans’ cell histiocytosis – Trials in Disease Leiomyosarcoma recurrent – Diagnostics Mantle cell lymphoma refractory – Treatment Antisynthetase syndrome – Life with Disease Anaplastic thyroid cancer – Treatment Atypical teratoid/rhabdoid tumour of CNS – Basic Information Bronchiolitis obliterans syndrome – Life with Disease Myxofibrosarcoma – Life with Disease Mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ethinylestradiol MARALIXIBAT Acetazolamide Oditrasertib Thiamine Nitrate Bp Cefuroxime Axetil Bgb-15025 Citrate Opevesostat Tosilate Misoprostol (-)-PHENSERINE TARTRATE Crizanlizumab Montelukast Sodium Rozanolixizumab Napabucasin GOCATAMIG Glipizide Bevacizumab Nitric Oxide Pbf-999 IMA401 More therapies…

    Learn about Your Condition

    Giant cell arteritis Drug eruption Pharyngeal cancer stage II Glomerulonephritis chronic Nephrolithiasis Diabetic ketoacidosis Pulmonary congestion Short-bowel syndrome Hepatobiliary cancer Hepatotoxicity Thalassaemia Muscle injury Proteus syndrome Head and neck cancer stage IV Respiratory distress More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Sodium Fluoride (18F) PET-CT Scans for Detecting Bone Changes in Psoriasis Patients at Risk of Psoriatic Arthritis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Sodium Fluoride (18F)
    The Netherlands

  • Study on Treating Neovascular Age-Related Macular Degeneration with Aflibercept, Ranibizumab, and Brolucizumab for Patients with Active Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • BROLUCIZUMAB
    • Ranibizumab
    • Aflibercept
    Austria

  • Study on the Effects of Lysergide for Patients with Chronic Cluster Headache

    Recruiting

    2 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • LYSERGIDE
    The Netherlands

  • Study on the Effects of DHEA and Melatonin on Sleep and Mood in Postmenopausal Women with Sleep Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Menopause
    • Sleep disorder
    Investigated Drugs:
    • Melatonin
    • Prasterone
    Poland

  • Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Pembrolizumab
    Belgium France

  • Study on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    • Adenocarcinoma pancreas
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium
Previous Page
1 … 246 247 248 249 250 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!